Global Psoriasis Therapeutics Market 2012-2016

Global Psoriasis Therapeutics Market 2012-2016

Category : Pharmaceuticals

TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

 

TechNavio's analysts forecast the Global Psoriasis Therapeutics market to grow at a CAGR of 4.06 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing uptake of biologics. The Global Psoriasis Therapeutics market has also been witnessing an increased focus on using combination therapies for treating psoriasis. However, the adverse side effects associated with psoriatic drugs could pose a challenge to the growth of this market. 
TechNavio's report, the Global Psoriasis Therapeutics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Psoriasis Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Amgen Inc., Pfizer Inc., Janssen Biotech Inc., and Abbvie Inc.
The other vendors mentioned in the report are AstraZeneca plc, Bristol Myers Squibb Co., Celgene Corp., Celgene Corp., Eisai Co. Ltd., Eli Lilly and Co., GlaxoSmithKline plc, Incyte Corp., Isotechnika Inc., LEO Pharma A/S, Merck & Co. Inc., and Novartis International AG
UCB S.A. Key questions answered in this report:
What will the market size be in 2016 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

 

 

01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Market Research Methodology


Market Research Process

Research Design

Research Methodology

05. Scope of the Report

Market Overview

Product Offerings

06. Types of Psoriasis

06.1 Types of Psoriasis Based on Forms

Plaque Psoriasis

Guttate Psoriasis

Inverse Psoriasis

Erythrodermic psoriasis

Pustular Psoriasis

06.2 Types of Psoriasis Based on Severity of Disease

07. Market Landscape

07.1 Global Psoriasis Therapeutics Market

Market Size and Forecast

07.2 Global Mild Psoriasis Therapeutics Market

07.3 Global Moderate Psoriasis Therapeutics Market

07.4 Global Severe Psoriasis Therapeutics Market

07.5 Five Forces Analysis

08. Geographical Segmentation

09. Rate of Incidence and Prevalence


Global Incidence and Prevalence

America

The UK

Asia

10. Pipeline Analysis

10.1 Topical Treatment Pipeline Analysis

10.2 Oral Treatment Pipeline Analysis

10.3 Injectable Treatment Pipeline Analysis

11. Vendor Landscape

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Key Vendor Analysis


18.1 Abbvie Inc.

Business Overview

Key Information

SWOT Analysis

18.2 Amgen Inc.

Business Overview

Key Information

SWOT Analysis

18.3 Janssen Biotech Inc.

Business Overview

Key Information

SWOT Analysis

18.4 Novartis International AG

Business Overview

Key Information

SWOT Analysis

18.5 Pfizer Inc.

Business Overview

Key Information

SWOT Analysis

19. Other Reports in this Series



List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Types of Psoriasis Based on Forms

Exhibit 3: Types of Psoriasis Based on Severity of Disease

Exhibit 4: Types of Psoriasis Based on Severity of Disease 2012

Exhibit 5: Global Psoriasis Therapeutics Market 2012-2016 (US$ billion)

Exhibit 6: Global Mild Psoriasis Therapeutics Market 2012 (in percentage)

Exhibit 7: Global Moderate Psoriasis Therapeutics Market 2012 (in percentage)

Exhibit 8: Global Severe Psoriasis Therapeutics Market 2012 (in percentage)

Exhibit 9: Global Psoriasis Therapeutics Market by Geographical Segmentation 2012

Exhibit 10: Business Segmentation of Novartis International AG

Exhibit 11: Business Segmentation of Pfizer Inc.



 


Enquiry Before Buy
image
Can´t read the image ? refresh here.